Sự khác biệt về cấu trúc và chuyển hóa vỏ não ở bệnh nhân đau nửa đầu mãn tính. Một nghiên cứu khám phá bằng 18FDG-PET và MRI
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lipton RB (2009) Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology 72(5 Suppl):S3–S7
Torres-Ferrús M, Ursitti F, Alpuente-Ruiz A, Brunello F, Chiappino D et al (2020) From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain J Headache Pain 21(1):42.
Pozo-Rosich P, Coppola G, Pascual J, Schwedt TJ. How does the brain change in chronic migraine? Developing disease biomarkers. Cephalalgia. 2020;333102420974359
Neeb L, Bastian K, Villringer K, Israel H, Reuter U, Fiebach JB. Structural Gray Matter Alterations in Chronic Migraine: Implications for a Progressive Disease? Headache. 2017;57(3):400–16
Chen Z, Chen X, Liu M, Liu S, Ma L, Yu S (2017) Volume expansion of periaqueductal gray in episodic migraine: a pilot MRI structural imaging study. J Headache Pain 18(1):83
Liu H-Y, Chou K-H, Lee P-L, Fuh J-L, Niddam DM, Lai K-L et al (2017) Hippocampus and amygdala volume in relation to migraine frequency and prognosis. Cephalalgia 37(14):1329–1336
Dominguez C, Lopez A, Ramos-Cabrer P, Vieites-Prado A, Perez-Mato M, Villalba C et al (2019) Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine. Neurology 92(10):e1076–e1085
Schulte LH, Allers A, May A (2017) Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI. Neurology 88(21):2011–2016
Schöll M, Damián A, Engler H (2014) Fluorodeoxyglucose PET in Neurology and Psychiatry. PET Clin 9(4):371–390
Schulte LH, May A (2016) Functional Neuroimaging in Migraine: Chances and Challenges. Headache 56(9):1474–1481
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808
Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto
Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio
Cohen S, Kamarck T, Mermelstein R (1983) A Global Measure of Perceived Stress. J Health Soc Behav 24(4):385–396
Ware JEJ, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. Mar 1;56(suppl 1):S20 LP-S28
Kosinski M, Bayliss MS, Bjorner JB, Ware JEJ, Garber WH, Batenhorst A et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12(8):963–974
Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ et al (2000) Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache 40(3):204–215
Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9(2):179–194
Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97(20):11050–11055
Lee MC, Tracey I, Colvin L, Rowbotham DJ (2013) Imaging pain: A potent means for investigating pain mechanisms in patients. Br J Anaesth 111(1):64–72
Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M et al (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129(2):543–550
Volkow ND, Fowler JS (2000) Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10(3):318–325
Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M et al (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129(Pt 2):543–550
Riederer F, Gantenbein AR, Marti M, Luechinger R, Kollias S, Sándor PS (2013) Decrease of Gray Matter Volume in the Midbrain is Associated with Treatment Response in Medication-Overuse Headache: Possible Influence of Orbitofrontal Cortex. J Neurosci 33(39):15343–15349
Magis D, D’Ostilio K, Thibaut A, De Pasqua V, Gerard P, Hustinx R et al (2017) Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia 37(9):881–891
Kim JH, Kim S, Suh S-I, Koh S-B, Park K-W, Oh K (2010) Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study. Cephalalgia 30(1):53–61
Kupers R, Kehlet H (2006) Brain imaging of clinical pain states: a critical review and strategies for future studies. Lancet Neurol 5(12):1033–1044
Lai K-L, Niddam DM, Fuh J-L, Chen W-T, Wu J-C, Wang S-J (2016) Cortical morphological changes in chronic migraine in a Taiwanese cohort: Surface- and voxel-based analyses. Cephalalgia 36(14):1324–1333
Woldeamanuel YW, DeSouza DD, Sanjanwala BM, Cowan RP (2019) Clinical Features Contributing to Cortical Thickness Changes in Chronic Migraine - A Pilot Study. Headache 59(2):180–191
Coppola G, Petolicchio B, Di Renzo A, Tinelli E, Lorenzo C, Di, Parisi V et al. Cerebral gray matter volume in patients with chronic migraine: correlations with clinical features The Journal of Headache and Pain. J Headache Pain. 2017;18